All items in the Healthy Skepticism Library
All the 20545 items in the Healthy Skepticism Library are listed below in order of publication date with the most recent at the top. There are 100 items per page.
Page 196 of 206 pages ‹ First < 194 195 196 197 198 > Last ›
HSL3252
Gabe L.
You can reach the hard-to-see MD!
Medical Marketing & Media 1984 Oct;19:63, 66, 68-69
HSL8383
Merchandising alert: new items push sales out front
National Association of Retail Druggists Journal 1984 Oct;106:10-11
HSL8391
Thompson RC.
Flaw in cytotoxic testing: there's no proof it works
FDA Consumer 1984 Oct;18:34-36
HSL3200
Lexchin J.
Pharmaceutical advertising in medical journals.
Can Med Assoc J 1984 Sep 15;131:(6):544-6
HSL3179
Some dodgy claims for pirbuterol (Exirel)--a beta 2 agonist.
Drug Ther Bull. 1984 Sep 10;22:(18):70-2
HSL8386
Rockwell T.
Rx ads to consumers at the threshold
Pharmaceutical Executive 1984 Sep;4:52, 54, 58
HSL8387
Prescription drug prices soar after years of moderate increases
American Pharmacy 1984 Sep;16-17
HSL8388
Abbott B.
Getting your OTC campaign in shape
Pharmaceutical Executive 1984 Sep;4:60, 62, 67
HSL8389
Fisher JJ.
Cautiously circling the issue of Rx consumer ads
Pharmaceutical Executive 1984 Sep;4:46, 50-51, 102
HSL8400
Jenne JW.
Unintentional overdose of theophylline: challenge to the pharmaceutical industry.
Clin Pharm 1984 Sep-Oct;3:(5):523-4
HSL3251
Joubert PH, Skene D.
Attitudes of private medical practitioners towards package inserts and other drug information sources.
S Afr Med J 1984 Aug 25;66:(8):306-7
http://www.ncbi.nlm.nih.gov/pubmed/6474294
HSL3246
Altman L.
Dealing with conflicts of interest [4th of 4 letters]
New England Journal of Medicine 1984 Aug 9;311:(6):405
HSL3247
Cohen SM.
Dealing with conflicts of interest [1st of 4 letters]
New England Journal of Medicine 1984 Aug 9;311:(6):404
HSL3248
Goldstone RA.
Dealing with conflicts of interest [2nd of 4 letters]
New England Journal of Medicine 1984 Aug 9;311:(6):404
HSL3249
Nightingale SD, Ansell D, Cohen M, Danel I, Hoffman A, Kiken S, Orris P, Patch O, Ringel P, Sable R, Schiff G, Schiff R, Sherer R, Shansky R, Trainor W, Tully J, Watson C, Kallal C.
Dealing with conflicts of interest [3rd of 4 letters]
New England Journal of Medicine 1984 Aug 9;311:(6):404-405
HSL3250
Relman AS.
Dealing with conflicts of interest [Editor's reply]
New England Journal of Medicine 1984 Aug 9;311:(6):405
HSL8392
Hildebrand N.
Physician and pharmacist: competing or essentially complementing?
Deutsche Apotheker Zeitung 1984 Aug 9;124:1573-1576
HSL8374
Final judgement on advertising-U.S. district court
American Pharmacy 1984 Aug;74-76
HSL3244
Collier JG, Pilkington TRE.
Human insulin: a misleading advertisement?
British Medical Journal 1984 Jul 21;289:191
HSL3245
Knight RK, Gennery BA.
Human insulin: a misleading advertisement? [reply]
British Medical Journal 1984 Jul 21;289:191
HSL3222
Wolffers I.
Telling doctors in a developing country about phenylbutazone.
Lancet 1984 Jul 7;2:(8393):44
HSL3241
MLAM’s first six months
MLAM Newsletter 1984 Jul 011-2
HSL3242
Re: the promotion of ethylestrenol
1984 Jul 01;
HSL3237
Mastroni N.
The industry is tuning out on direct-to-consumer advertising.
Med Mark Media 1984 Jul;19:(7):10-1,
HSL3243
Gouveia WA.
Hospital pharmacy and industry--conflict and collaboration.
Am J Hosp Pharm 1984 Jul;41:(7):1391-4
HSL13250
Adelson B.
When novices surpass experts: The difficulty of a task may increase with expertise.
Journal of Experimental Psychology: Learning, Memory, and Cognition 1984 Jul;10:(3):483-495
http://content.apa.org/journals/xlm/10/3/483
HSL20533
Herxheimer A.
Immortality for old drugs?
The Lancet 1984 Jun 30;1:(8392):1460-1.
http://www.ncbi.nlm.nih.gov/pubmed/6145891
HSL20526
Health minister recieves rational health declaration
The Lancet 1984 Jun 16;(i):1172-73
HSL20527
The People's Health
The Lancet 1984 Jun 16;(i):1172-73
HSL3180
Bansinath M, Sequeira RP, Shukla VK, Mathur VS.
Brand versus generic prescribing: a perspective of the Indian cardiologists' viewpoint.
Int J Clin Pharmacol Ther Toxicol 1984 Jun;22:(6):279-83
HSL8404
Rantucci M, Segal HJ.
Public awareness: assessment of the public response to a display illustrating community pharmacists' roles and services
Canadian Pharmaceutical Journal 1984 Jun;117:272-275
HSL8405
Gunston G.
Pharmaceutical marketing: but my market is different
Pharmaceutical Journal 1984 May 12;232:588-589
HSL3238
Re: the promotion of Lomotil
1984 May 01;
HSL3239
Donald AG.
Doctors and the pharmaceutical industry
Journal of the Royal College of General Practitioners 1984 May;34:301
HSL3240
Liebman M.
Prescription drug advertising to the general public.
Hosp Pract (Off Ed) 1984 May;19:(5):13,
HSL13372
Gallus M.
Under The Sugar Coating
The Globe and Mail (Canada) 1984 Apr 21
HSL3192
Crompton GK, Grant IW.
Pirbuterol.
Lancet 1984 Apr 7;1:(8380):795
HSL3234
Re: the promotion of dipyrone
1984 Apr 01;
HSL3235
Physicians, pharmacists, and consumers react to a direct-to-consumer campaign
Medical Marketing & Media 1984 Apr 01;19:(4):24, 26
HSL3218
Tse CS, Mansur JM.
Drug industry response time.
Drug Intell Clin Pharm 1984 Apr;18:(4):325
HSL3236
Atkinson AJ Jr, Becker RE, Galletti PM, Jefferis JE, Wroblewski R.
University and pharmaceutical industry cooperation: the need to plan for the future.
Clin Pharmacol Ther 1984 Apr;35:(4):431-7
HSL3185
Collier J.
The Medicines Act and the ABPI code.
Lancet 1984 Mar 24;1:(8378):682-3
HSL8399
Maclay WP, Crowder D, Spiro S, Turner P.
Postmarketing surveillance: practical experience with ketotifen.
Br Med J (Clin Res Ed) 1984 Mar 24;288:(6421):911-4
http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&pubmedid=6423140
HSL3233
Urbanski A.
Drug marketers write an Rx for consumers
Sales & Marketing Management 1984 Mar 12;132:74-75, 78
HSL8408
Spink JD.
Parallel imports
Pharmaceutical Journal 1984 Mar 10;232:275-276
HSL3190
Cox P.
Rules of conduct and the pharmaceutical industry.
Lancet 1984 Mar 3;1:(8375):517
HSL3232
Coffman K.
Drug companies can help educate your patients . . . if only you’d let them
Canadian Doctor 1984 Mar33-35
HSL3187
Collier J.
Rules of conduct and the pharmaceutical industry.
Lancet 1984 Feb 25;1:(8374):453
HSL3189
Collier J, New L.
Illegibility of drug advertisements.
Lancet 1984 Feb 11;1:(8372):341-2
HSL3231
Murphy DH.
Direct to consumer advertising of prescription drugs. FDA's first round of tests
Am Pharm. 1984 Feb 01;24:(2):20-3
HSL3230
Manners S.
All the news that’s fit to print: dealing with what your patients read
Canadian Doctor 1984 Feb36-39
HSL3228
Cousins J.
Payments to doctors and the responsibilities of ethics committees [2nd of 2 letters]
British Medical Journal 1984 Jan 28;288:323
HSL3229
Diamond A, Robinson K.
Payments to doctors and the responsibilities of ethics committees [1st of 2 letters]
British Medical Journal 1984 Jan 28;28:322-323
HSL3226
Survey: Consumers don't favor prescription drug advertising
American Pharmacy 1984 Jan 01;24:(1):10
HSL3198
Kunin CM.
The relation between clinical investigators and the pharmaceutical industry.
Rev Infect Dis 1984 Jan-Feb;6:(1):129-31
HSL3227
Powell SH, Stempien MJ, Vogenberg FR.
Hospital-based training for pharmaceutical manufacturers' representatives.
Am J Hosp Pharm 1984 Jan;41:(1):70,
HSL8441
Bass MA.
Look alikes: methinks the brand name companies protest too much
Pharmaceutical Executive 1984 Jan;4:42-43
HSL8444
Survey: consumers don't favor prescription drug advertising
American Pharmacy 1984 Jan;10
HSL2040
Braithwaite J.
Corporate crime in the pharmaceutical industry.
London: Routledge & Kegan Paul 1984
http://www.amazon.com/exec/obidos/tg/detail/-/0710200498/qid=1124498017/sr=1-1/ref=sr_1_1/002-4340062-2313626?v=glance&s=books
HSL3175
Advertiser wins CMAJ award
Canadian Medical Association Journal 1984;131:58
HSL3176
Drug companies at a European congress
Lancet 1984;2:1031
HSL3177
MLAM
Lancet 1984;2:861
HSL3178
Organon censured for marketing of anabolic steroids in developing countries
Lancet 1984;1:155
HSL3181
Bass MJ.
Chairman’s chair: research or marketing?
Family Medicine Research Update 1984;3:(2):6-7
HSL3182
Berner MS.
‘Misleading’ drug ad
Canadian Family Physician 1984;30:271-272
HSL3183
Buckley EG.
Preventing promotion
Journal of the Royal College of General Practitioners 1984;37:473
HSL3184
Burley DM, Thomson TJ
Doctors and the drug makers
Lancet 1984;2:404-405
HSL3191
Cox PJ.
Doctors and the drug makers
Lancet 1984;2:580
HSL3193
Hemminki E, Enlund H, Hellevuo K, Laurila R, Turakka H.
Trade names and generic names: Problems for prescribing physicians
Scandinavian Journal of Primary Health Care 1984;2:84-87
HSL3194
Henderson IWD.
Pharmaceutical advertising in medical journals
Canadian Medical Association Journal 1984;131:546
HSL3195
Herdman RC.
University-Industrial Relationships.
Cancer Invest 1984;2:(1):61-6
HSL3196
Hoff LC.
Advertising prescription drugs direct to the public: What are the issues?
Vitsl Speeches of the Day 1984;50:573-576
HSL3199
Laporte JR, Porta M, Capella D, Arnau JM.
Drugs in the Spanish health system.
Int J Health Serv 1984;14:(4):635-48
HSL3201
Lexchin J.
Reader upset at CFPC’s involvement in prescribing survey
Canadian Family Physician 1984;30:1454
HSL3202
Lexchin J.
The real pushers: a critical analysis of the Canadian drug industry
1984;
HSL3203
Massam ADW.
Legibility of advertisements
Lancet 1984;2:1397
HSL3204
Massam ADW.
Misleading advertisements
Lancet 1984;2:1159
HSL3205
Massie BM, Rothenberg D.
Impact of pharmaceutical industry funding of clinical research: results of a survey of antianginal trials
Circulation 1984;70:390
HSL3206
Morgan PP.
Pharmaceutical advertising in medical journals
Canadian Medical Association Journal 1984;130:1412
HSL3207
Morris LA, Millstein LG.
Drug advertising to consumers: effects of formats for magazine and television advertisements
Food Drug Cosmetic Law Journal 1984;39:497-503
HSL3208
Novitch M.
Direct-to-consumer advertising of prescription drugs
Food Drug Cosmetic Law Journal 1984;39:306-311
HSL3209
Parboosingh J, Lockyer J, McDougall G, Chugh U.
How physicians make changes in their clinical practice: a study of physicians’ perception of factors that facilitate this process
Annals of the Royal College of Physicians and Surgeons of Canada 1984;17:429-435
HSL3210
Peay MY, Peay ER.
Differences among practitioners in patterns of preference for information sources in the adoption of new drugs.
Soc Sci Med 1984;18:(12):1019-25
HSL3211
Philbrook FA.
‘Misleading’ drug ad
Canadian Family Physician 1984;30:272, 274
HSL3214
Rice DI.
The CFPC’s executive director replies
Canadian Family Physician 1984;30:1454-1455
HSL3215
Rosner F.
Is academia going into business?
Cancer Invest 1984;2:(6):493-5
HSL3216
Schapiro R.
Rx: consumer ads. Promoting prescription drugs to the consumer
New Physician 1984;33:(4):8-11
HSL3217
Timmers R.
Legibility of advertisements
Lancet 1984;2:1396
HSL3219
Turner J.
World health assembly
Lancet 1984;1:1172-1173
HSL3220
Transnational corporations in the pharmaceutical industry of developing countries
1984;
HSL3221
Walden RJ.
Doctors and the drug makers
Lancet 1984;2:405
HSL3223
Wright T.
Legibility of advertisements
Lancet 1984;2:1396
HSL3224
Yarrow M.
Doctors and the drug makers
Lancet 1984;2:405
HSL8396
Wolcott DL, Fawzy FI, Coombs RH.
Reinforcing networks: medical, pharmaceutical, mass media and paraphernalia establishments
Journal of Drug Issues 1984;14:(2):223-231
HSL8398
Legislation Part 10: Control of smoking, alcoholism, and drug abuse: Drug abuse (narcotics, psychotropic drugs, and other dependence producing drugs)
International Digest of Health Legislation 1984;35:(2):351-354
HSL8401
Vidt DG.
Comparative clinical trials--a clinical perspective.
Drug Inf J 1984;18:(2):185-8
HSL8832
Hailey A.
Strong Medicine: A Novel
Pan: London 1984
http://www.amazon.com/Strong-Medicine-Novel-Arthur-Hailey/dp/0385504098/ref=si3_rdr_bb_product/102-3968322-5585731
HSL9038
Adams S.
Adams vs Roche.
London: Jonathan Cape 1984
http://www.amazon.com/Roche-Versus-Adams-Stanley/dp/022402180X/ref=sr_1_1/102-1249992-1219339?ie=UTF8&s=books&qid=1174977505&sr=8-1
HSL9076
Medawar C.
Drugs and World Health
London: Social Audit 1984
http://www.socialaudit.org.uk/122order.htm#1.22%20How%20to%20order
HSL16710
Bargmann E, Wolfe S
Letter to the Editor concerning Benzodiazepines
NEJM 1984;310:465
Page 196 of 206 pages ‹ First < 194 195 196 197 198 > Last ›
